Tecfidera is an oral medication that researchers believe effectively inhibits immune system cells and molecules and acts as an anti-oxidant that potentially protects against demyelination and the loss of neurons that occurs in Multiple Sclerosis (MS).
In this MD Magazine TV video, learn more about how research is showing that long-term Tecfidera’s usage can be a good treatment option for patients with multiple sclerosis, especially in the early stages.
Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.